Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Neuronetics Inc (NQ: STIM )

2.518 -0.052 (-2.02%)
Streaming Delayed Price Updated: 2:58 PM EDT, Jun 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 85,268
Open 2.530
Bid (Size) 2.470 (1)
Ask (Size) 2.550 (4)
Prev. Close 2.570
Today's Range 2.370 - 2.606
52wk Range 2.010 - 6.952
Shares Outstanding 28,500,652
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Neuronetics Announces Increased TMS Access Through BlueCross BlueShield Of Michigan
Lower Medication Requirement Helps Depression Patients Obtain Treatment Sooner 
From Neuronetics
Via GlobeNewswire
New Depression Barometer Survey Shows Patients Are Stopping Treatment Due to Dissatisfaction
Lowest satisfaction among medication users, highest for users of non-drug solution TMS Therapy 
From Neuronetics
Via GlobeNewswire

Performance

YTD
-61.85%
-61.85%
1 Month
+14.46%
+14.46%
3 Month
-51.67%
-51.67%
6 Month
-59.38%
-59.38%
1 Year
-13.76%
-13.76%

More News

Read More
Neuronetics Wins 2023 Bell Seal for Workplace Mental Health
From Neuronetics
Via GlobeNewswire
Neuronetics's Return On Capital Employed Overview
Via Benzinga
Preview: Neuronetics's Earnings
Via Benzinga
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR
From Neuronetics
Via GlobeNewswire
Neuronetics Inks Six-Year Exclusive Partnership With Greenbrook TMS
Via Benzinga
Neuronetics's Return On Capital Employed Overview
Via Benzinga
Earnings Scheduled For May 9, 2023
Via Benzinga
Neuronetics Showcases New NeuroStar® TMS Findings at Clinical TMS Society Annual Meeting
From Neuronetics
Via GlobeNewswire
NeuroStar® Expands “Tap Into Possibility” Campaign in Honor of Mental Health Awareness Month
From Neuronetics
Via GlobeNewswire
Neuronetics Announces Lisa Metzner-Rosas as SVP, Chief Marketing Officer
From Neuronetics
Via GlobeNewswire
Neuronetics Announces Expanded TMS Access through United HealthCare
From Neuronetics
Via GlobeNewswire
Neuronetics Announces Continued Momentum for Expanded Health Insurance Coverage for TMS Therapy
From Neuronetics
Via GlobeNewswire
NeuroStar® Advanced Therapy Enhanced With Wi-Fi Capabilities
From Neuronetics
Via GlobeNewswire
NeuroStar® Advanced Therapy Receives Patient Impact Award from Life Sciences PA
From Neuronetics
Via GlobeNewswire
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
Via Benzinga
Neuronetics Announces TMS Coverage Criteria Changes for Over 23 Million Covered Lives
From Neuronetics
Via GlobeNewswire
Neuronetics Expands NeuroStar® Advanced Therapy’s Proprietary TrakStar® Platform
From Neuronetics
Via GlobeNewswire
Neuronetics Sponsors the 5th International Brain Stimulation Conference
From Neuronetics
Via GlobeNewswire
Neuronetics Announces Elevation of Sara Grubbs to SVP, Chief Revenue Officer
From Neuronetics
Via GlobeNewswire
Neuronetics Announces Updated Medicare Policy Expanding Access to NeuroStar TMS Therapy through Nurse Practitioners
From Neuronetics
Via GlobeNewswire
Neuronetics Announces Data Confirming Efficacy in Treating Anxious Depression with NeuroStar® Advanced Therapy for Mental Health
From Neuronetics
Via GlobeNewswire
Neuronetics Settles Unfair Competition Related Litigation Against BrainsWay
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.